MENU

EVMN Evommune Inc. Forecast, Technical & Fundamental Analysis

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVMN is expected to report earnings to fall 7.87% to -81 cents per share on December 10

Evommune Inc. EVMN Stock Earnings Reports
Q3'26
Est.
$-0.82
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.12
The last earnings report on August 07 showed earnings per share of -88 cents, missing the estimate of -68 cents. With 78.76K shares outstanding, the current market capitalization sits at 187.63M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLVX12.510.07
+0.56%
Nicholas Silver Income ETF (SLVX)
MOOD44.880.22
+0.48%
Relative Sentiment Tactical Allocation ETF (MOOD)
WIW7.940.01
+0.13%
Western Asset Inflation-Linked Opportunities & Income Fund
MDLV31.21-0.01
-0.04%
Morgan Dempsey Large Cap Value ETF (MDLV)
USRT62.28-0.43
-0.69%
iShares Core U.S. REIT ETF (USRT)
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1841 Page Mill Road
Phone
+1 925 247-4481
Employees
48
Web
https://www.evommune.com
Evommune (EVMN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com